GLP-1RA therapies
Heres how these weight loss drugs stack up against each other: 7
Ideal candidates for GLP-1 injections are adults who are clinically obese (BMI of 30 or higher) or those who are overweight (BMI of 27 or higher) and have one or more weight-related health conditions, such as high blood pressure or diabetes
In summary, targeting SLC1A5, GLS1, and glutamine metabolism presents a potential therapeutic strategy for treating pulmonary fibrosis, but further research is needed to refine these approaches
At follow-up, unadjusted analyses showed lower HbA1c in the GLP-1RA group (36 vs 44 mmol/mol, p = 0.03), but adjusted models revealed no statistically significant monthly HbA1c change ( 1.1, p = 0.308)
Reddit users often post about experiencing a weight loss plateau while taking a GLP-1 medication, even after an initial period of steady progress